Engel, Guthrie, Schrader, Hudson Introduce Bipartisan Legislation to Codify Current Prescription Drug Approval Practices
November 01, 2019
November 01, 2019
WASHINGTON, Nov. 1 -- Rep. Eliot Engel, D-New York, issued the following news release:
U.S. Representatives Eliot L. Engel, Brett Guthrie, Kurt Schrader and Richard Hudson, Members of the Energy and Commerce Health Subcommittee, have introduced the Protecting Access to Safe and Effective Medicines Act of 2019.
This bipartisan legislation would codify the Food and Drug Administration's current practices for evaluating new drugs for market exclusivity, which will help enc . . .
U.S. Representatives Eliot L. Engel, Brett Guthrie, Kurt Schrader and Richard Hudson, Members of the Energy and Commerce Health Subcommittee, have introduced the Protecting Access to Safe and Effective Medicines Act of 2019.
This bipartisan legislation would codify the Food and Drug Administration's current practices for evaluating new drugs for market exclusivity, which will help enc . . .